125th lecture series: Sir Bruce Ponder discusses genes and cancer, July 9

For the next event in the 125th Anniversary Lecture Series, the OHSU School of Medicine in conjunction with the Knight Cancer Institute invite you to a lecture from Sir Bruce Ponder, M.D., Ph.D., FRS, professor of oncology and director, Cancer Research UK Cambridge Research Institute, University of Cambridge.

When: July 9, 2013 at 4 p.m.
Where: OHSU Hospital, 8th floor auditorium
Who: All OHSU faculty, staff and trainees

About the lecture

Dr. Ponder will update us on his research to identify genes that underlie susceptibility to cancer and the practical applications of that knowledge. He will also discuss the essential role of collaboration between research and clinical entities to more rapidly translate discoveries into patient care, and realizing a future of personalized medicine. Dr. Ponder is world-renowned for his pioneering research into discovering genes that affect our risk of common cancers, particularly breast cancer. He is also investigating the genetics of lung cancer. Dr. Ponder’s team helped to identify the breast cancer susceptibility genes BRCA1 and BRCA2, and conducted the first genome wide association study in breast cancer.

Questions? Contact the School of Medicine Dean’s Office. No RSVP necessary.

Bookmark and Share

Comments are closed.

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives